Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Klotho and Fibroblast Growth Factor 23 in Chronic Kidney Disease-associated Pruritus and Their Response to Narrowband Ultraviolet B

NCT03532568 is registered in ClinicalTrials.gov with Cairo University as lead sponsor.

NCT NCT03532568
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03532568 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Klotho and Fibroblast Growth Factor 23 in Chronic Kidney Disease-associated Pruritus and Their Response to Narrowband Ultraviolet B
Lead sponsor
Cairo University
Phase
Not applicable
Overall status
Unknown status
Start date
May 31, 2018
Completion date
December 31, 2018
Enrollment
60 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease-associated pruritus